These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9269551)

  • 21. Cancer immunotherapy using tumor-infiltrating lymphocytes.
    Figlin RA
    Semin Hematol; 1992 Apr; 29(2 Suppl 1):33-5. PubMed ID: 1535456
    [No Abstract]   [Full Text] [Related]  

  • 22. Removing the primary tumor after the cancer has spread.
    Tannock IF
    N Engl J Med; 2001 Dec; 345(23):1699-700. PubMed ID: 11759650
    [No Abstract]   [Full Text] [Related]  

  • 23. [Spontaneous regression of pulmonary metastases in renal cancer].
    Rauh S; Duhem C; Ries F; Dicato M; Lamy S; Lens V
    Bull Soc Sci Med Grand Duche Luxemb; 1998; 135(1):39-42. PubMed ID: 9868831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II study.
    Bergmann L; Fenchel K; Weidmann E; Enzinger HM; Jahn B; Jonas D; Mitrou PS
    Cancer; 1993 Sep; 72(5):1733-42. PubMed ID: 8348502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metastatic RCC arising in a transplant kidney.
    Kunisch-Hoppe M; Hoppe M; Bohle RM; Rauber K; Weimar B; Friemann S; Stahl U; Rau WS
    Eur Radiol; 1998; 8(8):1441-3. PubMed ID: 9853232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunotherapy for metastatic renal cell cancer: effect on the primary tumor.
    Haas GP; Redman BG; Rao VK; Dybal E; Pontes JE; Hillman GG
    J Immunother Emphasis Tumor Immunol; 1993 Feb; 13(2):130-5. PubMed ID: 8318498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferons and interleukins in metastatic renal cell carcinoma.
    Choudhury M; Efros M; Mittelman A
    Urology; 1993 Jan; 41(1 Suppl):67-72. PubMed ID: 7678365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunology in clinical practice. XVII. Immunotherapy of metastatic renal cell carcinoma. Work Group Immunotherapy, Dutch Oncology].
    van Herpen CM; de Mulder PH
    Ned Tijdschr Geneeskd; 1998 Nov; 142(48):2613-8. PubMed ID: 10028361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunotherapy for renal cell carcinoma: the era of interleukin-2-based treatment.
    Taneja SS; Pierce W; Figlin R; Belldegrun A
    Urology; 1995 Jun; 45(6):911-24. PubMed ID: 7771023
    [No Abstract]   [Full Text] [Related]  

  • 30. Nephrectomy for metastatic renal-cell cancer.
    Copur MS; Ledakis P; Norvell M
    N Engl J Med; 2002 Apr; 346(14):1095-6. PubMed ID: 11936126
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunochemotherapy for metastatic renal cell carcinoma using a regimen of interleukin-2, interferon-alpha and 5-fluorouracil.
    Hofmockel G; Langer W; Theiss M; Gruss A; Frohmüller HG
    J Urol; 1996 Jul; 156(1):18-21. PubMed ID: 8648791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sarcomatoid differentiation as a prognostic factor for immunotherapy in metastatic renal cell carcinoma.
    Kwak C; Park YH; Jeong CW; Jeong H; Lee SE; Moon KC; Ku JH
    J Surg Oncol; 2007 Mar; 95(4):317-23. PubMed ID: 17066434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrative tumor board: metastatic renal cell carcinoma: medical oncology (II).
    Pandha H
    Integr Cancer Ther; 2004 Mar; 3(1):29-34. PubMed ID: 15035872
    [No Abstract]   [Full Text] [Related]  

  • 34. Cytoreductive surgery prior to interleukin-2-based therapy in patients with metastatic renal cell carcinoma.
    Walther MM; Alexander RB; Weiss GH; Venzon D; Berman A; Pass HI; Linehan WM; Rosenberg SA
    Urology; 1993 Sep; 42(3):250-7; discussion 257-8. PubMed ID: 8379024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of adoptive immunotherapy in solid cancers.
    Kruit WH; Stoter G
    Neth J Med; 1997 Feb; 50(2):47-68. PubMed ID: 9050332
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of advanced renal cancer.
    Atkins MB
    Kidney Int; 2005 May; 67(5):2069-82. PubMed ID: 15840065
    [No Abstract]   [Full Text] [Related]  

  • 37. [The role of immunotherapy in metastatic cancer of the kidney].
    Thiounn N
    J Urol (Paris); 1994; 100(5):231-7. PubMed ID: 7730669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible synergy of radiotherapy and chemo-immunotherapy in metastatic renal cell carcinoma (RCC).
    Brinkmann OA; Bruns F; Prott FJ; Hertle L
    Anticancer Res; 1999; 19(2C):1583-7. PubMed ID: 10365150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural history and therapy of metastatic renal cell carcinoma: the role of interleukin-2.
    Bukowski RM
    Cancer; 1997 Oct; 80(7):1198-220. PubMed ID: 9317170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic and predictive factors of immunotherapy in metastatic renal cell carcinoma.
    van Herpen CM; De Mulder PH
    Crit Rev Oncol Hematol; 2002 Mar; 41(3):327-34. PubMed ID: 11880208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.